Clinical Trial

Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy

Study acronym: ARTS-PIVOT
Recruiting
View on ClinicalTrials.gov →
Summary
The investigators initiated a multicenter, prospective, randomized, open label, blinded-endpoint (PROBE) controlled trial to evaluate the efficacy and safety of perfusion-guided endovascular treatment (EVT) compared to standard medical care for patients with acute ischemic stroke due to medium vessel occlusion (MeVO) within 24 hours from symptom onset.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-23.
Status change: Not Yet Recruiting → Recruiting 2026-02-08
Trial Details
NCT Number NCT07323368
Lead Sponsor Beijing Tiantan Hospital
Conditions Stroke Ischemic, Medium Vessel Occlusions
Enrollment 568 participants
Start Date 2026-02-08
Primary Completion 2027-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-10